| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2007 | 2013 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2007 | 2013 | ||||||||
|
Kruppel like factor 5 | 0.534 | 0.769 | 0.82 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 1999 | 2005 | ||||||||
|
p21 (RAC1) activated kinase 1 | 0.494 | 0.808 | 1.3E-03 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2009 | 2012 | ||||||||
|
fms related receptor tyrosine kinase 1 | 0.419 | 0.846 | 1.00 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 1997 | 2012 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
platelet derived growth factor subunit B | 0.488 | 0.846 | 0.77 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
slingshot protein phosphatase 1 | 0.769 | 0.192 | 3.3E-04 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
AXL receptor tyrosine kinase | 0.489 | 0.615 | 1.3E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
protein tyrosine phosphatase receptor type C | 0.435 | 0.808 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
selectin P | 0.460 | 0.769 | 5.0E-32 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
tissue factor pathway inhibitor | 0.486 | 0.808 | 0.25 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
YY1 transcription factor | 0.481 | 0.808 | 0.99 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
N-ribosyldihydronicotinamide:quinone reductase 2 | 0.628 | 0.500 | 8.8E-07 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
MYB proto-oncogene, transcription factor | 0.490 | 0.692 | 0.82 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
poly(ADP-ribose) polymerase 1 | 0.389 | 0.923 | 3.3E-04 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
cytochrome b-245 beta chain | 0.452 | 0.885 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
dopamine receptor D4 | 0.517 | 0.577 | 9.3E-09 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
endothelin converting enzyme 1 | 0.541 | 0.769 | 0.96 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
erb-b2 receptor tyrosine kinase 4 | 0.455 | 0.846 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
coagulation factor III, tissue factor | 0.415 | 0.846 | 1.9E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
protein tyrosine kinase 2 beta | 0.448 | 0.808 | 0.94 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 |